000			02321 a2200661 4500
005			20250516013528.0
264		0	_c20110321
008			201103s 0 0 eng d
022			_a1528-0020
024	7		_a10.1182/blood-2010-04-278853 _2doi
040			_aNLM _beng _cNLM
100	1		_aRoué, Gaël
245	0	0	_aThe Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in vitro and in vivo by down-regulation of the prosurvival ER chaperone BiP/Grp78. _h[electronic resource]
260			_bBlood _cJan 2011
300			_a1270-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aBenzoquinones _xpharmacology
650	0	4	_aBoronic Acids _xtherapeutic use
650	0	4	_aBortezomib
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aDown-Regulation _xdrug effects
650	0	4	_aDrug Resistance, Neoplasm _xdrug effects
650	0	4	_aEndoplasmic Reticulum Chaperone BiP
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Neoplastic _xdrug effects
650	0	4	_aGene Knockdown Techniques
650	0	4	_aHSP90 Heat-Shock Proteins _xantagonists & inhibitors
650	0	4	_aHeat-Shock Proteins _xgenetics
650	0	4	_aHumans
650	0	4	_aLactams, Macrocyclic _xpharmacology
650	0	4	_aLymphoma, Mantle-Cell _xdrug therapy
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, SCID
650	0	4	_aMice, Transgenic
650	0	4	_aMiddle Aged
650	0	4	_aMolecular Chaperones _xgenetics
650	0	4	_aPyrazines _xtherapeutic use
650	0	4	_aReceptors, Estrogen _xmetabolism
650	0	4	_aTumor Cells, Cultured
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aPérez-Galán, Patricia
700	1		_aMozos, Ana
700	1		_aLópez-Guerra, Mónica
700	1		_aXargay-Torrent, Sílvia
700	1		_aRosich, Laia
700	1		_aSaborit-Villarroya, Ifigènia
700	1		_aNormant, Emmanuel
700	1		_aCampo, Elias
700	1		_aColomer, Dolors
773	0		_tBlood _gvol. 117 _gno. 4 _gp. 1270-9
856	4	0	_uhttps://doi.org/10.1182/blood-2010-04-278853 _zAvailable from publisher's website
999			_c20400119 _d20400119